Advertisement.

OSMT Projected Dividend Yield

Osmotica Pharmaceuticals plc ( NASDAQ : OSMT )

Osmotica Pharmaceuticals is a holding company. Through its subsidiaries, Co. is focused on the development and commercialization of products that target markets with underserved patient populations. Co.'s promoted products include: M-72, which is for the treatment of attention deficit hyperactivity disorder (ADHD) in patients aged 13 to 65; Arbaclofen ER, which is for the treatment of multiple sclerosis spasticity; and OS870, which is for the treatment of neurodegenerative disorder. Co.'s non-promoted products include Methylphenidate ER, which is for the treatment of ADHD and Venlafaxine ER tablets, which is for the treatment of depressive disorder and social anxiety disorder.

20 YEAR PERFORMANCE RESULTS

OSMT Dividend History Detail
OSMT Dividend News
OSMT Competitors News

# of Shares: 0

Closing Price: 1.09

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000